NUP210 and primary biliary cholangitis: The measured sensitivity of anti-gp210 antibodies in PBC was found to be 44% [32], which is higher than that reported from other parts of the world: Japan–26% [43], Italy–18% or 27% [30,35,55], and Spain–33% [56].